带状疱疹疫苗在自身免疫性和炎性疾病患者中的长期有效性
Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
作者信息
Yun Huifeng, Xie Fenglong, Baddley John W, Winthrop Kevin, Saag Kenneth G, Curtis Jeffrey R
机构信息
From the University of Alabama at Birmingham, Birmingham, Alabama; Oregon Health and Science University, Portland, Oregon, USA.
H. Yun, PhD, University of Alabama at Birmingham; F. Xie, MS, University of Alabama at Birmingham; J.W. Baddley, MD, MPH, University of Alabama at Birmingham; K. Winthrop, MD, MPH, Oregon Health and Science University; K.G. Saag, MD, MSc, University of Alabama at Birmingham; J.R. Curtis, MD, MS, MPH, University of Alabama at Birmingham.
出版信息
J Rheumatol. 2017 Jul;44(7):1083-1087. doi: 10.3899/jrheum.160685. Epub 2017 Mar 15.
Abstract
OBJECTIVE
The protection duration of herpes zoster (HZ) vaccination is unclear among patients with autoimmune (AI) diseases.
METHODS
Using 2006-2013 Medicare data, HZ vaccinated patients with AI were matched 1:2 to unvaccinated HZ. Incidence rates (IR) and adjusted risk ratios over time were calculated using Poisson regression.
RESULTS
Of 59,627 vaccinated patients, crude IR increased from 0.75/100 person-years during the first year post-vaccination to 1.25 during the seventh year. Vaccinated patients had a significantly lower risk of HZ compared with the unvaccinated through 5 years.
CONCLUSION
HZ vaccination was significantly protective only for about 5 years among patients with AI.
摘要
目的
自身免疫性（AI）疾病患者中带状疱疹（HZ）疫苗的保护持续时间尚不清楚。
方法
利用2006 - 2013年医疗保险数据，将接种HZ疫苗的AI患者与未接种HZ疫苗的患者按1:2进行匹配。使用泊松回归计算随时间变化的发病率（IR）和调整后的风险比。
结果
在59627名接种疫苗的患者中，粗发病率从接种后第一年的0.75/100人年增加到第七年的1.25。在5年时间里，接种疫苗的患者患HZ的风险明显低于未接种疫苗的患者。
结论
HZ疫苗仅在约5年时间内对AI疾病患者具有显著保护作用。
相似文献
1
Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.带状疱疹疫苗在自身免疫性和炎性疾病患者中的长期有效性
J Rheumatol. 2017 Jul;44(7):1083-1087. doi: 10.3899/jrheum.160685. Epub 2017 Mar 15.
2
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.接种带状疱疹疫苗与特定免疫介导性疾病老年患者带状疱疹感染风险的相关性。
JAMA. 2012 Jul 4;308(1):43-9. doi: 10.1001/jama.2012.7304.
3
The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.带状疱疹疫苗在炎症性和自身免疫性疾病患者中的使用、安全性和有效性：一项纵向观察性研究。
Arthritis Res Ther. 2011;13(5):R174. doi: 10.1186/ar3497. Epub 2011 Oct 24.
4
Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.65 岁及以上的 Medicare 人群中，减毒活带状疱疹疫苗提供的保护效力和持续时间。
Clin Infect Dis. 2017 Mar 15;64(6):785-793. doi: 10.1093/cid/ciw854.
5
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.带状疱疹在自身免疫性和炎症性疾病中的风险：疫苗接种的意义。
Arthritis Rheumatol. 2016 Sep;68(9):2328-37. doi: 10.1002/art.39670.
6
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.带状疱疹疫苗与尽管接种了带状疱疹疫苗仍发生带状疱疹的患者的带状疱疹后神经痛风险
J Infect Dis. 2015 Oct 15;212(8):1222-31. doi: 10.1093/infdis/jiv244. Epub 2015 Jun 1.
7
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.带状疱疹疫苗在60岁及以上终末期肾病患者中的有效性。
Clin Infect Dis. 2016 Feb 15;62(4):462-7. doi: 10.1093/cid/civ930. Epub 2015 Dec 14.
8
Vaccination against zoster remains effective in older adults who later undergo chemotherapy.带状疱疹疫苗对随后接受化疗的老年人仍然有效。
Clin Infect Dis. 2014 Oct;59(7):913-9. doi: 10.1093/cid/ciu498. Epub 2014 Aug 4.
9
Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.带状疱疹活疫苗在炎症性肠病患者中的疗效。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1341-1347. doi: 10.1016/j.cgh.2018.10.016. Epub 2018 Oct 13.
10
Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.评估带状疱疹疫苗活疫苗的效果：一项利用英国初级保健数据的回顾性队列研究。
Vaccine. 2018 Nov 12;36(46):7105-7111. doi: 10.1016/j.vaccine.2018.08.037. Epub 2018 Sep 5.
引用本文的文献
1
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 5 版。
Arthritis Rheumatol. 2023 Jan;75(1):E1-E16. doi: 10.1002/art.42372. Epub 2022 Nov 8.
2
Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis.在免疫功能正常和免疫功能低下的受试者中，带状疱疹疫苗的疗效、效果和安全性：系统评价和网络荟萃分析。
Front Immunol. 2022 Sep 30;13:978203. doi: 10.3389/fimmu.2022.978203. eCollection 2022.
3
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.美国风湿病学会风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种指南：第 4 版。
Arthritis Rheumatol. 2022 May;74(5):e21-e36. doi: 10.1002/art.42109.
4
Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case-control study.JAK 抑制剂治疗类风湿关节炎的韩国患者带状疱疹的风险因素：一项巢式病例对照研究。
RMD Open. 2022 Jan;8(1). doi: 10.1136/rmdopen-2021-001892.
5
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 3 版。
Arthritis Rheumatol. 2021 Oct;73(10):e60-e75. doi: 10.1002/art.41928. Epub 2021 Aug 4.
6
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 2 版。
Arthritis Rheumatol. 2021 Aug;73(8):e30-e45. doi: 10.1002/art.41877. Epub 2021 Jun 15.
7
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.美国风湿病学会关于风湿性和肌肉骨骼疾病患者接种新冠病毒疫苗的指南：第1版
Arthritis Rheumatol. 2021 Jul;73(7):1093-1107. doi: 10.1002/art.41734. Epub 2021 May 24.
8
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.韩国自身免疫性炎性风湿病患者疫苗接种实践指南。
Infect Chemother. 2020 Jun;52(2):252-280. doi: 10.3947/ic.2020.52.2.252.
9
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.成人自身免疫性炎症性风湿病患者疫苗接种的疗效、免疫原性和安全性：2019 年 EULAR 建议更新的系统文献回顾。
RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.
10
Varicella zoster virus vaccines: an update.水痘带状疱疹病毒疫苗：最新进展
Immunotargets Ther. 2019 Aug 6;8:15-28. doi: 10.2147/ITT.S176383. eCollection 2019.
本文引用的文献
1
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.带状疱疹在自身免疫性和炎症性疾病中的风险：疫苗接种的意义。
Arthritis Rheumatol. 2016 Sep;68(9):2328-37. doi: 10.1002/art.39670.
2
Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.带状疱疹疫苗在60岁及以上成年人中的效力下降
J Infect Dis. 2016 Jun 15;213(12):1872-5. doi: 10.1093/infdis/jiw047. Epub 2016 Feb 9.
3
Long-term persistence of zoster vaccine efficacy.带状疱疹疫苗效力的长期持续性。
Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi: 10.1093/cid/ciu918. Epub 2014 Nov 20.
4
Herpes zoster.带状疱疹
N Engl J Med. 2013 Oct 31;369(18):1766-7. doi: 10.1056/NEJMc1310369.
5
Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.带状疱疹疫苗对美国老年人群中带状疱疹和带状疱疹后神经痛的有效性：一项队列研究。
PLoS Med. 2013;10(4):e1001420. doi: 10.1371/journal.pmed.1001420. Epub 2013 Apr 9.
6
Postherpetic neuralgia after herpes zoster vaccination.
JAMA. 2012 Oct 10;308(14):1427; author reply 1427-8. doi: 10.1001/jama.2012.12736.
7
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.带状疱疹疫苗预防研究及短期持续性亚研究中带状疱疹疫苗疗效的持久性。
Clin Infect Dis. 2012 Nov 15;55(10):1320-8. doi: 10.1093/cid/cis638. Epub 2012 Jul 24.
8
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.接种带状疱疹疫苗与特定免疫介导性疾病老年患者带状疱疹感染风险的相关性。
JAMA. 2012 Jul 4;308(1):43-9. doi: 10.1001/jama.2012.7304.
9
Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.A/H1N1 疫苗接种对免疫介导性疾病的保护作用——一项前瞻性对照疫苗研究。
Rheumatology (Oxford). 2012 Apr;51(4):695-700. doi: 10.1093/rheumatology/ker389. Epub 2011 Dec 14.
10
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.使用多个医疗保健数据系统对生物安全性进行综合评估的研究设计。
Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1199-209. doi: 10.1002/pds.2196. Epub 2011 Sep 15.
Zotero 插件